glp-1 weight loss drugs tirzepatide semaglutide Novo, Lilly weight-loss should be first option obesity treatments, European doctors say GLP-1 Genetics: How Genes Affect

That's like trying to mop up a flood while the faucet is still running full blast

A 2025 study published in Obesity found that GLP1 users lost 7.7% of body weight on semaglutide and 12.4% on tirzepatide after one year, roughly half the weight loss seen in randomized trials

Preclinical work may test peptides first in cell cultures or animal models where scientists can measure direct effects on follicle growth, mitochondrial function, or hormone signaling

To transform preliminary findings into robust clinical guidance, future research must prioritize methodological rigor, targeted populations, and mechanistic clarity

PMID 37973897

Manage stress and trauma